STOCK TITAN

[144] Becton, Dickinson and Co. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Becton, Dickinson and Co. (BDX) Form 144 shows a proposed sale of 917 common shares through Merrill Lynch on 09/10/2025, with an aggregate market value of $171,862.50. The filer acquired these shares as a stock bonus on 01/23/2025 from Claire Marie Fraser and paid by stock bonus on the same date. The filing also discloses a recent sale of 863 shares on 08/08/2025 for gross proceeds of $165,879.90. Outstanding shares are listed as 286,627,469, making these transactions a very small fraction of total shares outstanding.

Becton, Dickinson and Co. (BDX): la Form 144 indica una proposta di vendita di 917 azioni ordinarie tramite Merrill Lynch il 09/10/2025, per un valore complessivo di mercato di $171.862,50. Il dichiarante ha ricevuto queste azioni come stock bonus il 01/23/2025 da Claire Marie Fraser e le ha pagate con lo stesso tipo di bonus nella stessa data. La comunicazione segnala inoltre una recente vendita di 863 azioni il 08/08/2025 per proventi lordi di $165.879,90. Le azioni in circolazione sono 286.627.469, pertanto queste operazioni rappresentano una quota molto piccola del totale.

Becton, Dickinson and Co. (BDX): la Form 144 muestra una propuesta de venta de 917 acciones ordinarias a través de Merrill Lynch el 09/10/2025, con un valor de mercado agregado de $171,862.50. El declarante adquirió estas acciones como una stock bonus el 01/23/2025 de Claire Marie Fraser y las pagó como stock bonus en la misma fecha. El documento también revela una venta reciente de 863 acciones el 08/08/2025 por ingresos brutos de $165,879.90. Las acciones en circulación son 286,627,469, por lo que estas transacciones representan una fracción muy pequeña del total.

Becton, Dickinson and Co. (BDX)의 Form 144에 따르면 09/10/2025에 Merrill Lynch를 통해 917 보통주를 매도할 예정이며 총 시가액은 $171,862.50입니다. 신고인은 해당 주식을 01/23/2025에 Claire Marie Fraser로부터 stock bonus로 취득했고 같은 날 동일한 방식으로 대금을 지급했습니다. 제출서류에는 또한 08/08/2025863주를 최근 매도하여 총 매각대금 $165,879.90을 확보했다는 내용이 포함되어 있습니다. 발행주식수는 286,627,469주로, 이 거래들은 전체 주식 대비 매우 작은 비중입니다.

Becton, Dickinson and Co. (BDX) : la Form 144 indique une proposition de vente de 917 actions ordinaires via Merrill Lynch le 09/10/2025, pour une valeur de marché totale de $171,862.50. Le déclarant a acquis ces actions en tant que stock bonus le 01/23/2025 de Claire Marie Fraser et les a payées sous forme de stock bonus à la même date. Le dossier révèle également une vente récente de 863 actions le 08/08/2025 pour des produits bruts de $165,879.90. Le nombre d'actions en circulation est de 286,627,469, ce qui fait de ces opérations une part très faible du total.

Becton, Dickinson and Co. (BDX): In der Form 144 wird ein geplanter Verkauf von 917 Stammaktien über Merrill Lynch am 09/10/2025 mit einem aggregierten Marktwert von $171.862,50 angegeben. Der Meldende erhielt diese Aktien am 01/23/2025 als stock bonus von Claire Marie Fraser und zahlte am selben Tag ebenfalls per Stock-Bonus. Die Einreichung gibt außerdem einen jüngsten Verkauf von 863 Aktien am 08/08/2025 mit Bruttoerlösen von $165.879,90 an. Die ausstehenden Aktien betragen 286.627.469, sodass diese Transaktionen einen sehr kleinen Anteil am Gesamtkapital darstellen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider plans a routine sale of newly received stock bonus totaling 917 shares; transaction size is immaterial to BDX capitalization.

The Form 144 documents a proposed sale and a recent sale by or for the account of a person who received a stock bonus. The proposed sale value of $171,862.50 versus total outstanding shares of 286,627,469 implies a de minimis ownership impact. There is no disclosure here of material nonpublic information or unusual trading arrangements; acquisition and payment are recorded as stock bonus. From a market-impact perspective, this filing appears routine and not material to investors.

TL;DR: Filing meets Rule 144 disclosure of proposed insider sale; no governance or compliance red flags evident from the form.

The form includes the required representations about lack of material nonpublic information and documents the broker, dates, quantities, and consideration (stock bonus). The inclusion of a prior sale in the three-month window (863 shares) provides useful transaction history. Absent additional context or related-party complexity, this appears to be a standard Rule 144 notice consistent with regulatory expectations.

Becton, Dickinson and Co. (BDX): la Form 144 indica una proposta di vendita di 917 azioni ordinarie tramite Merrill Lynch il 09/10/2025, per un valore complessivo di mercato di $171.862,50. Il dichiarante ha ricevuto queste azioni come stock bonus il 01/23/2025 da Claire Marie Fraser e le ha pagate con lo stesso tipo di bonus nella stessa data. La comunicazione segnala inoltre una recente vendita di 863 azioni il 08/08/2025 per proventi lordi di $165.879,90. Le azioni in circolazione sono 286.627.469, pertanto queste operazioni rappresentano una quota molto piccola del totale.

Becton, Dickinson and Co. (BDX): la Form 144 muestra una propuesta de venta de 917 acciones ordinarias a través de Merrill Lynch el 09/10/2025, con un valor de mercado agregado de $171,862.50. El declarante adquirió estas acciones como una stock bonus el 01/23/2025 de Claire Marie Fraser y las pagó como stock bonus en la misma fecha. El documento también revela una venta reciente de 863 acciones el 08/08/2025 por ingresos brutos de $165,879.90. Las acciones en circulación son 286,627,469, por lo que estas transacciones representan una fracción muy pequeña del total.

Becton, Dickinson and Co. (BDX)의 Form 144에 따르면 09/10/2025에 Merrill Lynch를 통해 917 보통주를 매도할 예정이며 총 시가액은 $171,862.50입니다. 신고인은 해당 주식을 01/23/2025에 Claire Marie Fraser로부터 stock bonus로 취득했고 같은 날 동일한 방식으로 대금을 지급했습니다. 제출서류에는 또한 08/08/2025863주를 최근 매도하여 총 매각대금 $165,879.90을 확보했다는 내용이 포함되어 있습니다. 발행주식수는 286,627,469주로, 이 거래들은 전체 주식 대비 매우 작은 비중입니다.

Becton, Dickinson and Co. (BDX) : la Form 144 indique une proposition de vente de 917 actions ordinaires via Merrill Lynch le 09/10/2025, pour une valeur de marché totale de $171,862.50. Le déclarant a acquis ces actions en tant que stock bonus le 01/23/2025 de Claire Marie Fraser et les a payées sous forme de stock bonus à la même date. Le dossier révèle également une vente récente de 863 actions le 08/08/2025 pour des produits bruts de $165,879.90. Le nombre d'actions en circulation est de 286,627,469, ce qui fait de ces opérations une part très faible du total.

Becton, Dickinson and Co. (BDX): In der Form 144 wird ein geplanter Verkauf von 917 Stammaktien über Merrill Lynch am 09/10/2025 mit einem aggregierten Marktwert von $171.862,50 angegeben. Der Meldende erhielt diese Aktien am 01/23/2025 als stock bonus von Claire Marie Fraser und zahlte am selben Tag ebenfalls per Stock-Bonus. Die Einreichung gibt außerdem einen jüngsten Verkauf von 863 Aktien am 08/08/2025 mit Bruttoerlösen von $165.879,90 an. Die ausstehenden Aktien betragen 286.627.469, sodass diese Transaktionen einen sehr kleinen Anteil am Gesamtkapital darstellen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does BDX Form 144 filed for 09/10/2025 disclose?

The Form 144 discloses a proposed sale of 917 common shares through Merrill Lynch on 09/10/2025 with aggregate market value $171,862.50.

How were the 917 BDX shares acquired?

The filer acquired the 917 shares on 01/23/2025 as a stock bonus from Claire Marie Fraser, with payment recorded as stock bonus.

Did the filer sell any BDX shares recently?

Yes, the filing reports a sale on 08/08/2025 of 863 shares for gross proceeds of $165,879.90.

How large are these transactions relative to BDX shares outstanding?

Outstanding shares are listed as 286,627,469, so the proposed sale of 917 shares represents a negligible fraction of total shares.

Who is the broker handling the proposed sale?

The broker listed is Merrill Lynch at the address shown in the filing.
Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

54.01B
284.96M
0.57%
92.26%
1.59%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES